Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Afamelanotide is the active ingredient in FDA-approved products for erythropoietic protoporphyria (EPP)
Key effects include: Delivers bioavailable copper to activate critical copper-dependent enzymes Stimulates collagen, elastin, and glycosaminoglycan production, helping skin, tendons, and connective tissues regenerate Accelerates wound healing and supports remodeling of old or fibrotic tissue Regulates matrix metalloproteinases (MMPs) to balance tissue breakdown and rebuilding Reduces inflammation by lowering cytokines such as TNF-, IL-6, and TGF- Provides antioxidant protection by boosting copper-dependent enzymes Supports hair follicle health and dermal papilla cell activity Influences gene expression related to repair, regeneration, and cell protection Improves tissue resilience in skin, muscle, and joint structures May support cognitive and neural protection through antioxidant and anti-inflammatory mechanisms Key Research Areas and Potential Benefits 1
The results found that BPC-157 treatment caused the redistribution of trapped blood volume and counteracted these effects [8]
Reported effects with oral use skew toward mild gastrointestinal changes nausea, appetite shifts, or stomach discomfort
At Mintel, our Consultants work with clients to predict how micro and macro consumer trends could affect their innovation and marketing strategies in the future not just in the next 24 months, but over the next 10 years
US$ 20.26
US$ 20.70
US$ 27.74
US$ 28.61
US$ 28.21
US$ 23.07
